bioRxiv · 11 Nov 2026
Programmable amide bond formation using de novo ligases
Saman Salikeh-index 2, Timo Fluegel, Maximilian Gantz, Stanislav S Moroz, Andrew C Hunt, Henry Jones, Abhishek Singh, Nathaniel Corley, Kieran Didi, Rafael I Brent, Maxwell W Kazman, Zefei Xu, Christina Savvides, Seth Michael Woodbury, Belen Sotomayor, Hannah Nguyen, Johnny Mendoza, Alex Kang, Asim K Bera, Xinting Li, Sambashiva Banala, Jasper Butcher, Luke D Lavis, Anthony P Green, Donald Hilvert, David Bakerh-index 182
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Amide bond formation is of central importance in the chemical industry, underpinning the synthesis of small bioactive molecules, macrocycles, peptides and their conjugates. Conventional methods of amide synthesis rely on stoichiometric coupling agents and costly protecting group manipulations. While biocatalysis can alleviate some of these challenges, enzymes typically operate across a narrow range of substrates and their adaptation to new coupling partners requires extensive engineering. Here we show that de novo amide ligases featuring a cysteine catalytic triad can be programmed computationally to operate across diverse substrate classes with high selectivity. We first designed complementary peptide ligases to selectively functionalise either the N-terminus or a single lysine residue of a polypeptide sequence containing 36 competing lysines. Crystal structures of both ligases show excellent agreement with the designs, with structural modelling suggesting that amidation outcompetes hydrolysis because the catalytically competent geometry forms only upon acceptor binding. We then extended our approach to the synthesis of small bioactive molecules by designing stereoselective ligases that mediate a key amide bonding forming step in the synthesis of the preventative HIV therapeutic lenacapavir. These results establish de novo enzyme design as a programmable platform for achieving selective amide bond formations across a wide range of molecular targets.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- David Baker has the highest h-index among the authors (182).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.